Liquidia Corporation (NASDAQ:LQDA) Given Consensus Recommendation of “Moderate Buy” by Analysts
by Renee Jackson · The Cerbat GemShares of Liquidia Corporation (NASDAQ:LQDA – Get Free Report) have been given a consensus recommendation of “Moderate Buy” by the twelve brokerages that are covering the stock, Marketbeat reports. Two equities research analysts have rated the stock with a sell rating, one has issued a hold rating, seven have assigned a buy rating and two have assigned a strong buy rating to the company. The average 1 year target price among brokers that have issued a report on the stock in the last year is $43.4444.
Several equities research analysts have recently issued reports on LQDA shares. Wall Street Zen raised shares of Liquidia from a “hold” rating to a “buy” rating in a research report on Saturday, March 7th. BTIG Research increased their price objective on shares of Liquidia from $49.00 to $50.00 and gave the stock a “buy” rating in a research report on Thursday, March 5th. Jefferies Financial Group increased their price objective on shares of Liquidia from $45.00 to $55.00 and gave the stock a “buy” rating in a research report on Tuesday, January 13th. Raymond James Financial reissued a “strong-buy” rating on shares of Liquidia in a research report on Thursday, March 5th. Finally, Lifesci Capital raised shares of Liquidia to a “strong-buy” rating in a research report on Thursday, March 5th.
View Our Latest Analysis on LQDA
Insider Activity
In other news, CAO Dana Boyle sold 1,580 shares of the company’s stock in a transaction on Monday, January 26th. The shares were sold at an average price of $41.65, for a total value of $65,807.00. Following the completion of the transaction, the chief accounting officer directly owned 178,848 shares in the company, valued at approximately $7,449,019.20. This represents a 0.88% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, insider Scott Moomaw sold 18,314 shares of the company’s stock in a transaction on Monday, March 23rd. The shares were sold at an average price of $36.79, for a total transaction of $673,772.06. Following the completion of the transaction, the insider owned 187,640 shares of the company’s stock, valued at $6,903,275.60. This trade represents a 8.89% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold a total of 83,132 shares of company stock valued at $3,016,281 over the last ninety days. 30.10% of the stock is owned by company insiders.
Institutional Inflows and Outflows
Several institutional investors and hedge funds have recently made changes to their positions in LQDA. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its stake in shares of Liquidia by 4.7% in the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 37,681 shares of the company’s stock valued at $556,000 after purchasing an additional 1,700 shares during the period. Goldman Sachs Group Inc. boosted its stake in shares of Liquidia by 10.7% in the first quarter. Goldman Sachs Group Inc. now owns 861,231 shares of the company’s stock valued at $12,703,000 after purchasing an additional 82,955 shares during the period. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC boosted its stake in shares of Liquidia by 15.2% in the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 121,756 shares of the company’s stock valued at $1,796,000 after purchasing an additional 16,022 shares during the period. Creative Planning boosted its stake in shares of Liquidia by 40.7% in the second quarter. Creative Planning now owns 26,840 shares of the company’s stock valued at $334,000 after purchasing an additional 7,765 shares during the period. Finally, Swiss National Bank boosted its stake in shares of Liquidia by 24.2% in the second quarter. Swiss National Bank now owns 122,200 shares of the company’s stock valued at $1,523,000 after purchasing an additional 23,800 shares during the period. 64.54% of the stock is currently owned by hedge funds and other institutional investors.
Liquidia Stock Performance
Shares of LQDA stock opened at $38.55 on Monday. Liquidia has a one year low of $11.85 and a one year high of $46.67. The company has a debt-to-equity ratio of 2.97, a quick ratio of 1.84 and a current ratio of 2.01. The company has a 50 day moving average price of $36.98 and a 200 day moving average price of $32.80. The firm has a market capitalization of $3.40 billion, a price-to-earnings ratio of -46.45 and a beta of 0.45.
Liquidia (NASDAQ:LQDA – Get Free Report) last issued its quarterly earnings results on Thursday, March 5th. The company reported $0.15 EPS for the quarter, topping the consensus estimate of $0.08 by $0.07. Liquidia had a negative net margin of 43.53% and a negative return on equity of 209.33%. The firm had revenue of $92.02 million during the quarter, compared to analyst estimates of $87.49 million. The company’s revenue for the quarter was up 3072.4% compared to the same quarter last year. Sell-side analysts anticipate that Liquidia will post -1.51 EPS for the current year.
Liquidia Company Profile
Liquidia Technologies, Inc is a clinical-stage biopharmaceutical company headquartered in Research Triangle Park, North Carolina. The company leverages its proprietary PRINT® (Particle Replication In Non-wetting Templates) platform to engineer precisely shaped and sized drug particles, with the goal of improving delivery, efficacy and safety profiles. By controlling particle characteristics at the nanoscale, Liquidia seeks to enhance respiratory and other therapies that depend on targeted delivery.
The company’s lead product candidate, LIQ861, is a dry powder formulation of treprostinil designed for inhalation in patients with pulmonary arterial hypertension (PAH).